Showing results (401-410 of 912) with videos related to
Sort By:
Pageof 92
Annals of General Psychiatry|November 1, 2012
Sexual obsessions and suicidal behaviors in patients with mood disorders, panic disorder and schizophreniaLiliana Dell'osso, Giulia Casu, Marina Carlini, et al.Annals of General Psychiatry|August 14, 2020
Suicide ideation, attempt, and determinants among medical students Northwest Ethiopia: an institution-based cross-sectional studyGetachew Tesfaw Desalegn, Mesele Wondie, Saron Dereje, et al.Annals of General Psychiatry|November 15, 2012
Stress-related asthma and family therapy: Case studyMaria Theodoratou-Bekou, Ourania Andreopoulou, Panoraia Andriopoulou, et al.Annals of General Psychiatry|November 20, 2012
Estimated economic benefits from low-frequency administration of atypical antipsychotics in treatment of schizophrenia: a decision modelNicolas M Furiak, James C Gahn, Robert W Klein, et al.Annals of General Psychiatry|May 15, 2014
Psychotropic drugs and driving: prevalence and typesFrancisco Alonso, Cristina Esteban, Luis Montoro, et al.Annals of General Psychiatry|May 16, 2014
Paliperidone extended release for the treatment of pediatric and adolescent patients with Tourette's disorderKazuhiko Yamamuro, Manabu Makinodan, Toyosaku Ota, et al.Annals of General Psychiatry|March 20, 2015
The development and trial of a medication discontinuation program in the department of forensic psychiatryKenji Murasugi, Teruomi Tsukahara, Shinsuke WashizukaAnnals of General Psychiatry|June 27, 2012
Effects of eszopiclone on safety, subjective measures of efficacy, and quality of life in elderly and nonelderly Japanese patients with chronic insomnia, both with and without comorbid psychiatric disorders: a 24-week, randomized, double-blind studyNaohisa Uchimura, Atsushi Kamijo, Takao TakaseAnnals of General Psychiatry|January 30, 2015
Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response-a prospective open-label studyNaoki Hashimoto, Atsuhito Toyomaki, Minoru Honda, et al.Annals of General Psychiatry|July 10, 2012
Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drugJin Mizushima, Keisuke Takahata, Noriko Kawashima, et al.Pageof 92